slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 72,121-72,150
Pages 3,679
Rows per page 30
Component
72,121-72,150 of 110,355
29
The slide uses a 2x2 grid layout to present segment-specific revenue and prescription growth data.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
30
Unconsolidated data; 1.U.S. wholesales inventoryBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
31
The slide presents unconsolidated inventory data for specific business units.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
33
Includes reported and constant currency comparisons.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
34
Includes footnotes regarding non-GAAP measures and dilutive share calculations.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
35
The table provides a detailed breakdown of various operating expenses and adjustments across two fiscal periods.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
The table provides a detailed breakdown of adjustments including impairments, restructuring costs, and other non-GAAP adjustments.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
05
The slide uses a comparison matrix to contrast 'Others' with 'Advantage' (Benson Hill) across five pillars, emphasizing a 6-10 year lead.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a horizontal arrow timeline with events placed above and below the line.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Loop · Why Now1 hit
19
Includes reconciliation for mark-to-market timing differences and highlights key operational drivers.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · FinancialsLoop · Why Now1 hit
20
Includes adjustments for 'Open Mark-to-Market Timing differences' and excludes 'Fresh Business'.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Financials1 hit
29
Includes two distinct reconciliation tables: one for Adjusted EBITDA and one for Free Cash Flow.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations 1 hit
30
Includes two separate reconciliation tables for Adjusted EBITDA and Free Cash Flow.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations 1 hit
03
Includes company mission, business model summary, target market sizing, and key performance indicators.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
05
The slide uses two distinct bar charts to illustrate market size and federal spending growth.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
17
Includes acquisition of ProModel Commercial in April 2022.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Financials1 hit
19
Includes non-GAAP measure disclosure.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Financials1 hit
06
The slide uses a visual comparison between healthy cells (alkaline) and cancer cells (acidic) to demonstrate the selective binding mechanism.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a waterfall plot for response and a spider plot for longitudinal tumor burden change.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
12
Includes a spider plot for target lesion change and a Kaplan-Meier survival curve with a summary table.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
14
The slide uses a decision tree/process flow to map patient cohorts to clinical outcomes and subsequent trial progression.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
15
Includes specific clinical trial data (N=73 and N=26) and detailed breakdown of specific adverse events like constipation, neuropathy, and diarrhea.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
16
Includes detailed footnotes for data sources and medical abbreviations.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
17
The chart is a classic waterfall plot used in oncology to show tumor shrinkage/growth.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a process-oriented layout to describe clinical trial progression.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Traction1 hit
19
Data cut-off Jan 4, 2023. Includes partial and complete responses.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Traction1 hit
20
Includes waterfall plot (left) and spider plot (right) for patient response data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
21
Includes specific clinical trial safety metrics and footnotes regarding data definitions.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
22
The table displays specific drug administration schedules (mg/kg) for different cycle lengths and days.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
25
The slide uses a combination of high-level market statistics and specific clinical benchmarks to define the target opportunity.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit